These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 2673456

  • 1. Normal myeloid progenitors (CFU-GM) in multiple myeloma: a preliminary study in view of autologous BMT.
    Lemoli RM, Visani G, Gobbi M, Rizzi S, Dinota A, Tassi C, Tosi P, Galieni P, Cavo M, Tura S.
    Bone Marrow Transplant; 1989 Jul; 4(4):373-7. PubMed ID: 2673456
    [Abstract] [Full Text] [Related]

  • 2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 3. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N, Mohamed R.
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [Abstract] [Full Text] [Related]

  • 4. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 5. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
    Douay L, Gorin NC, Mary JY, Lemarie E, Lopez M, Najman A, Stachowiak J, Giarratana MC, Baillou C, Salmon C.
    Exp Hematol; 1986 Jun; 14(5):358-65. PubMed ID: 3519263
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard-Zollinger L, Keating A.
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [Abstract] [Full Text] [Related]

  • 7. Myeloid progenitor cells (CFU-GM) predict engraftment kinetics in autologous transplantation in children.
    Emminger W, Emminger-Schmidmeier W, Höcker P, Hinterberger W, Gadner H.
    Bone Marrow Transplant; 1989 Jul; 4(4):415-20. PubMed ID: 2673462
    [Abstract] [Full Text] [Related]

  • 8. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
    Jansen EM, Hanks SG, Terry C, Akard LP, Thompson JM, Dugan MJ, Jansen J.
    Transfusion; 2007 May; 47(5):817-23. PubMed ID: 17465946
    [Abstract] [Full Text] [Related]

  • 9. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [Abstract] [Full Text] [Related]

  • 10. Failure of bone marrow cryopreservation in chronic granulocytic leukemia: relation to excessive granulo-macrophagic progenitor pool.
    Douay L, Lopez M, Gorin NC, Nauman A, Giarratana MC, Laporte JP, Stachowiak J, Salmon C, Duhamel G.
    Int J Cell Cloning; 1986 Jul; 4(4):250-62. PubMed ID: 2875118
    [Abstract] [Full Text] [Related]

  • 11. [Mobilization of circulating hematopoietic stem cells by granulocyte colony stimulating factor after chemotherapy in multiple myeloma].
    Ohler L, Scholten C, Reiter E, Tiefengraber E, Jäger U, Strobl H, Lechner K, Höcker P, Geissler K.
    Wien Klin Wochenschr; 1993 Jul; 105(20):580-4. PubMed ID: 7505076
    [Abstract] [Full Text] [Related]

  • 12. [Granulocyte-macrophage progenitor cells in allogenic bone marrow transplantation: correlation of progenitor cell content and regeneration in the graft].
    Gidáli J, Poros A, Harsányi V, Fehér I, Mód A, Hollán Z.
    Orv Hetil; 1989 Oct 15; 130(42):2251-4, 2257. PubMed ID: 2812758
    [Abstract] [Full Text] [Related]

  • 13. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun 15; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 14. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D, Strife A, Atzpodien J, Clarkson BD.
    Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231
    [Abstract] [Full Text] [Related]

  • 15. Phase I study of in vivo lenograstim (rHuG-CSF) for stem cell collection demonstrates improved neutrophil recovery after autologous bone marrow transplantation.
    Stoppa AM, Blaise D, Viens P, Baume D, Mannoni P, Novakovitch G, David FA, Yver A, Maraninchi D.
    Bone Marrow Transplant; 1994 May 15; 13(5):541-7. PubMed ID: 7519936
    [Abstract] [Full Text] [Related]

  • 16. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY.
    J Immunol; 1986 Jun 15; 136(12):4487-95. PubMed ID: 3086433
    [Abstract] [Full Text] [Related]

  • 17. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
    Weisdorf D, Miller J, Verfaillie C, Burns L, Wagner J, Blazar B, Davies S, Miller W, Hannan P, Steinbuch M, Ramsay N, McGlave P.
    Biol Blood Marrow Transplant; 1997 Oct 15; 3(4):217-23. PubMed ID: 9360784
    [Abstract] [Full Text] [Related]

  • 18. [Kinetics of hematopoiesis after high-dose chemotherapy and autologous peripheral stem cell transplantation].
    Mayer J, Korístek Z, Pospísil Z, Vásová I, Adam Z, Hájek R, Krejcí M, Král Z, Navrátil M, Vorlícek J, Bourková L, Matýsková M, Adler J, Vinklárková J, Klabusay M, Koutná I, Hoffová V, Schmitzová D, Janovská E.
    Cas Lek Cesk; 1999 Mar 15; 138(6):170-7. PubMed ID: 10510531
    [Abstract] [Full Text] [Related]

  • 19. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
    Bentley SA, Brecher ME, Powell E, Serody JS, Wiley JM, Shea TC.
    Bone Marrow Transplant; 1997 Mar 15; 19(6):557-63. PubMed ID: 9085735
    [Abstract] [Full Text] [Related]

  • 20. Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation.
    Takamatsu Y, Harada M, Teshima T, Makino S, Inaba S, Akashi K, Shibuya T, Niho Y.
    Exp Hematol; 1995 Jan 15; 23(1):8-13. PubMed ID: 7527786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.